La presentazione è in caricamento. Aspetta per favore

La presentazione è in caricamento. Aspetta per favore

Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with.

Presentazioni simili


Presentazione sul tema: "Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with."— Transcript della presentazione:

1 Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide  Marco C. Merlano, Anna M. Merlotti, Lisa Licitra, Nerina Denaro, Elena Fea, Danilo Galizia, Massimo Di Maio, Claudia Fruttero, Paola Curcio, Stefania Vecchio, Elvio G. Russi, Renzo Corvò  Clinical and Translational Radiation Oncology  Volume 12, Pages (August 2018) DOI: /j.ctro Copyright © 2018 The Authors Terms and Conditions

2 Fig. 1 Study schema. Clinical and Translational Radiation Oncology  , 47-52DOI: ( /j.ctro ) Copyright © 2018 The Authors Terms and Conditions


Scaricare ppt "Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with."

Presentazioni simili


Annunci Google